Global Information
회사소개 | 문의 | 비교리스트

혈장 요법 시장 : 규모, 점유율, 전망, 기회 분석(2020-2027년)

Plasma Therapy Market, By Type (Pure PRP, Leucocyte-rich PRP, Pure Platelet-rich Fibrin, and Leukocyte-rich Fibrin ), By Application, By End-User and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

리서치사 Coherent Market Insights
발행일 2020년 09월 상품코드 968687
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 4,500 ₩ 6,506,000 PDF (Single User License)
US $ 7,000 ₩ 10,120,000 PDF (Multi User License)
US $ 10,000 ₩ 14,458,000 PDF (Enterprise User License)


혈장 요법 시장 : 규모, 점유율, 전망, 기회 분석(2020-2027년) Plasma Therapy Market, By Type (Pure PRP, Leucocyte-rich PRP, Pure Platelet-rich Fibrin, and Leukocyte-rich Fibrin ), By Application, By End-User and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
발행일 : 2020년 09월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

혈장 요법은 코로나바이러스 및 많은 희귀 심각한 질환에 대한 유망한 치료법입니다. 규제기관은 코로나바이러스에 감염된 환자의 새로운 치료 옵션을 개발하기 위한 임상시험의 시행에 관심을 가지고 있습니다.

세계의 혈장 요법 시장에 대해 조사분석했으며, 시장 개요, 시장 규모와 예측, 부문별 시장 분석, 지역별 시장 분석, 경쟁 구도 등에 관한 정보를 정리하여 전해드립니다.

목차

제1장 조사 목적과 전제조건

제2장 시장 개요

  • 리포트 설명
  • 개요
  • 기회 맵(COM)

제3장 시장 역학·규제·동향 분석

  • 시장 역학
    • 촉진요인
    • 억제요인
    • 시장 기회
  • 영향 분석
  • 시장 동향
  • 주요 발전
  • 전략
  • 규제 시나리오
  • 신제품 발매/승인
  • Porter의 산업 분석
  • PEST 분석

제4장 COVID-19의 영향 분석

  • COVID-19 전 시장 시나리오
  • COVID-19 후 시장 시나리오
  • 전략

제5장 세계의 혈장 요법 시장 : 유형별

  • 서론
  • 퓨어 PRP
  • 다백혈구 PRP
  • PRF(Pure Platelet-rich Fibrin)
  • 다백혈구 피브린(L-PRF)

제6장 세계의 혈장 요법 시장 : 적응별

  • 서론
  • 감염증
  • 치과
  • 신경 손상
  • 심근 손상
  • 기타

제7장 세계의 혈장 요법 시장 : 최종사용자별

  • 서론
  • 병원·클리닉
  • 연구기관
  • 기타

제8장 세계의 혈장 요법 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 아프리카
  • 중동

제9장 경쟁 구도

  • 기업 개요
    • Octapharma AG
    • China Biologic Products Holdings, Inc.
    • Bio Products Laboratory Ltd.
    • Kedrion SpA
    • Grifols, SA
    • CSL
    • Biotest AG
    • Takeda Pharmaceutical Company Limited
    • DePuy Synthes
    • Regen Lab SA
    • LFB SA
    • Immunotek Bio Centers.

제10장 섹션

KSA 20.11.20

Title:
Plasma Therapy Market, By Type (Pure PRP, Leucocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), and Leukocyte-rich Fibrin (L-PRF)), By Application (Infections Diseases, Dental, Nerve Injury, Cardiac Muscle Injury, and Other Applications), By End-User (Hospitals & Clinics, Research Institutes, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

  • Plasma therapy is a promising treatment against coronavirus, and many rare and serious disorders. The blood which is donated by the donor is processed in a processing facility to obtain plasma. Similarly, for treatment of coronavirus infected patients, the plasma is isolated from the donor. The donor is also the patient who is recovered from the infection. The donor plasma consists of antibodies which were generated in order to fight the antigens i.e. the coronavirus. The blood from the donor is processed in processing centers which is then injected in the blood of the patients.

Market Dynamics

  • Regulatory authorities are interested in conducting clinical trials for development of new treatment options for coronavirus infected patients. For instance, on 18th April 2020, The Drug Controller General of India accepted the proposal of the Indian Council of Medical Research (ICMR) for conducting clinical trials of convalescent plasma in COVID-19 patients. The ICMR has submitted a list of institutes which are interested in the trial.
  • In convalescent plasma therapy, the antibodies are recovered from the blood of patients who have recovered from COVID-19 and are injected in the blood of injected patients. The clinical trial aims to assess the efficacy of convalescent plasma to limit complications in COVID-19 patients and to evaluate the safety of treatment with anti SARS-CoV-2 plasma in coronavirus-infected patients. The rising number of clinical trials is expected to increase treatment options for coronavirus infected patients and spur the global plasma therapy market growth during the forecast period.
  • Companies are receiving approvals from regulatory authorities for the setup of a new manufacturing facility. For instance, in 2019, Takeda Pharmaceutical Company Limited received approval from the U.S Food and Drug Administration (U.S FDA) for its new pharmaceutical manufacturing facility near Covington, Georgia. The facility will produce FLEXBUMIN 25% [Albumin (Human), USP, 25% Solution]. The medicine is indicated for hypovolemia, hypoalbuminemia, (burns, Adult Respiratory Distress Syndrome, and nephrosis, cardiopulmonary bypass surgery, and hemolytic disease of newborns. The new facility will expand the product portfolio of the company which is expected to favor the global plasma therapy market growth during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global plasma therapy market, market size (US$ 226.13 Mn), and compound annual growth rate (CAGR (14.1 %)) for the forecast period (2020-2027), considering 2019 as the base year.
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global plasma therapy market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies.
  • Key players covered as a part of this study are Octapharma AG, China Biologic Products Holdings, Inc. Bio Products Laboratory Ltd., Kedrion S.p.A, Grifols, S.A., CSL, Biotest AG., Takeda Pharmaceutical Company Limited., DePuy Synthes, Regen Lab SA, LFB SA, and Immunotek Bio Centers.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global plasma therapy market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for plasma therapy market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Plasma Therapy Market, By Type:
  • Pure PRP
  • Leucocyte-rich PRP
  • Pure Platelet-rich Fibrin (PRF)
  • Leukocyte-rich Fibrin (L-PRF)
  • Global Plasma Therapy Market, By Application:
  • Infectious Diseases
  • Dental
  • Nerve Injury
  • Cardiac Muscle Injury
  • Other Applications
  • Global Plasma Therapy Market, By End User:
  • Hospitals & Clinics
  • Research Institutes
  • Others
  • Global Plasma Therapy Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
    • By Type:
  • Pure PRP
  • Leucocyte-rich PRP
  • Pure Platelet-rich Fibrin (PRF)
  • Leukocyte-rich Fibrin (L-PRF)
    • By Application
  • Infectious Diseases
  • Dental
  • Nerve Injury
  • Cardiac Muscle Injury
  • Other Applications
    • By End-User
  • Hospitals & Clinics
  • Research Institutes
  • Others
  • Europe
    • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
    • By Type:
  • Pure PRP
  • Leucocyte-rich PRP
  • Pure Platelet-rich Fibrin (PRF)
  • Leukocyte-rich Fibrin (L-PRF)
    • By Application
  • Infectious Diseases
  • Dental
  • Nerve Injury
  • Cardiac Muscle Injury
  • Other Applications
    • By End-User
  • Hospitals & Clinics
  • Research Institutes
  • Others
  • Asia Pacific
    • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
    • By Type:
  • Pure PRP
  • Leucocyte-rich PRP
  • Pure Platelet-rich Fibrin (PRF)
  • Leukocyte-rich Fibrin (L-PRF)
    • By Application
  • Treatments of Infections
  • Dental
  • Nerve Injury
  • Cardiac Muscle Injury
  • Other Applications
    • By End-User
  • Hospitals & Clinics
  • Research Institutes
  • Others
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
    • By Type:
  • Pure PRP
  • Leucocyte-rich PRP
  • Pure Platelet-rich Fibrin (PRF)
  • Leukocyte-rich Fibrin (L-PRF)
    • By Application
  • Infectious Diseases
  • Dental
  • Nerve Injury
  • Cardiac Muscle Injury
  • Other Applications
    • By End-User
  • Hospitals & Clinics
  • Research Institutes
  • Others
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
    • By Type:
  • Pure PRP
  • Leucocyte-rich PRP
  • Pure Platelet-rich Fibrin (PRF)
  • Leukocyte-rich Fibrin (L-PRF)
    • By Application
  • Infectious Diseases
  • Dental
  • Nerve Injury
  • Cardiac Muscle Injury
  • Other Applications
    • By End-User
  • Hospitals & Clinics
  • Research Institutes
  • Others
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
    • By Type:
  • Pure PRP
  • Leucocyte-rich PRP
  • Pure Platelet-rich Fibrin (PRF)
  • Leukocyte-rich Fibrin (L-PRF)
    • By Application
  • Infectious Diseases
  • Dental
  • Nerve Injury
  • Cardiac Muscle Injury
  • Other Applications
    • By End-User
  • Hospitals & Clinics
  • Research Institutes
  • Others
  • Company Profiles
    • Octapharma AG
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • China Biologic Products Holdings, Inc.
    • Bio Products Laboratory Ltd.
    • Kedrion S.p.A.
    • Grifols, S.A.
    • CSL, Biotest AG.
    • Takeda Pharmaceutical Company Limited.
    • DePuy Synthes
    • Regen Lab SA
    • LFB SA
    • Immunotek Bio Centers.
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Application
    • Market Snippet, By End-User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Strategies
  • Regulatory Scenario
  • New Product Launches/Approvals
  • Porter's Analysis
  • PEST Analysis

4. COVID - 19 Impact Analysis

  • Pre COVID-19 Market Scenario
  • Post COVID-19 Market Scenario
  • Strategies

5. Global Plasma Therapy Market, By Type, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Pure PRP
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Leucocyte-rich PRP
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Pure Platelet-rich Fibrin (PRF)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Leukocyte-rich Fibrin (L-PRF)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

6. Global Plasma Therapy Market, By Application, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Dental
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Nerve Injury
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Cardiac Muscle Injury
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

7. Global Plasma Therapy Market, By End User, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospitals & Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

8. Global Plasma Therapy Market, By Region, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2027
    • Regional Trends
  • North America
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End-User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End-User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End-User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End-User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End-User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End-User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East

9. Competitive Landscape

  • Company Profiles
    • Octapharma AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • China Biologic Products Holdings, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Bio Products Laboratory Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Kedrion S.p.A
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Grifols, S.A.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • CSL
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Biotest AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Takeda Pharmaceutical Company Limited.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • DePuy Synthes
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Regen Lab SA
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • LFB SA
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Immunotek Bio Centers.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top
전화 문의
F A Q